医学部 乳腺外科

Hiroshi Yamaguchi

  (山口 博司)

Profile Information

Affiliation
Radiology Division Theragnostics Centre, Fujita Health University Hospital

ORCID ID
 https://orcid.org/0009-0008-0980-1767
researchmap Member ID
B000230480

Specializing in in-house production of radiopharmaceuticals, quality control, and system-level workflow design, he focuses on optimizing the entire operational framework of radiopharmaceutical practice, including PET tracer synthesis, QC, supply management, and education systems.
In recent years, his work has emphasized the development of sustainable operational systems in clinical settings by integrating troubleshooting experiences and practical knowledge into structured workflows and educational resources.

After graduating from the Faculty of Engineering at Tottori University, he pursued graduate studies in material and biological informatics at the Graduate School of Human Informatics, Nagoya University. He subsequently engaged in research and technical development in both industry and research institutions, including the National Institute of Advanced Industrial Science and Technology (AIST), the National Center for Geriatrics and Gerontology, and Nagoya University, and obtained a doctoral degree in protein chemistry. He is currently involved in the production and operational management of radiopharmaceuticals at Fujita Health University Hospital.


Major Papers

 8

Major Misc.

 3
  • Hiroshi Yamaguchi
    Unpublished Technical Report (Institutional Document), Apr, 2026  Lead authorLast authorCorresponding author
    This report presents a structured operational protocol for sustainable 18F-FDG production in hospital-based radiopharmaceutical facilities. The protocol integrates routine workflow, troubleshooting processes, and education-driven system design to ensure stable and safe production. Rather than treating operational issues as isolated events, this framework systematically converts troubleshooting experiences into standardized workflows and training resources. This approach enables continuous system improvement and transforms operational variability into structured system resilience in radiopharmaceutical practice.